Элизабет Блэкберн - Эффект теломер - революционный подход к более молодой, здоровой и долгой жизни

45. Glaesmer, H., et al., “Psychometric Properties and Population-Based Norms of the Life Orientation Test Revised (LOT – R),” British Journal of Health Psychology 17, no. 2 (May 2012): 432–445, doi:10.1111/ j.2044–8287.2011.02046.x.

46. Eckhardt, Christopher, Bradley Norlander, and Jerry Deffenbacher. “The Assessment of Anger and Hostility: A Critical Review.” Aggression and Violent Behavior 9, no. 1 (January 2004): 17–43. doi:10.1016/ S1359–1789 (02) 00116–7.

47. Brydon et al., “Hostility and Cellular Aging in Men from the Whitehall II Cohort.” (See 4 above.)

48. Trapnell, P. D., and J. D. Campbell, “Private Self-Consciousness and the Five-Factor Model of Personality: Distinguishing Rumination from Reflection,” Journal of Personality and Social Psychology 76, no. 2 (February 1999) 284–304.

49. Ibid; and Trapnell, P.D., “Rumination – Reflection Questionnaire (RRQ) Shortforms,” unpublished data, University of British Columbia (1997).

50. Ibid.

51. John, O. P., E.M. Donahue, and R. L. Kentle, R. L., The Big Five Inventory – Versions 4a and 54 (Berkeley: University of California, Berkeley, Institute of Personality and Social Research, 1991). We thank Dr. Oliver John of UC Berkeley for permission to use this scale. John, O. P., and S. Srivastava, “The Big – Five Trait Taxonomy: History, Measurement, and Theoretical Perspectives,” in Handbook of Personality: Theory and Research , ed. L. A. Pervin and O. P. John, 2nd ed. (New York: Guilford Press, 1999): 102–138.

52. Sadahiro, R., et al., “Relationship Between Leukocyte Telomere Length and Personality Traits in Healthy Subjects,” European Psychiatry 30, no. 2 (February 2015): 291–295, doi:10.1016/j.eurpsy.2014.03.003, pmid: 24768472.

53. Srivastava, S., et al., “Development of Personality in Early and Middle Adulthood: Set Like Plaster or Persistent Change?” Journal of Personality and Social Psychology 84, no. 5 (May 2003): 1041–1053, doi:10.1037/0022–3514.84.5.1041.

54. Ryff, C. D., and C. L. Keyes, “The Structure of Psychological Wellbeing Revisited,” Journal of Personality and Social Psychology 69, no. 4 (October 1995): 719–727.

55. Scheier, M. F., et al., “The Life Engagement Test: Assessing Purpose in Life,” Journal of Behavioral Medicine 29, no. 3 (June 2006): 291–298, doi:10.1007/s10865–005–9044–1.

56. Pearson, E. L., et al., “Normative Data and Longitudinal Invariance of the Life Engagement Test (LET) in a Community Sample of Older Adults,” Quality of Life Research 22, no. 2 (March 2013): 327–331, doi:10.1007/s11136–012–0146–2.

1. Whiteford, H. A., et al., “Global Burden of Disease Attributable to Mental and Substance Use Disorders: Findings from the Global Burden of Disease Study 2010,” Lancet 382, no. 9904 (November 9, 2013): 1575–1586, doi:10.1016/S0140–6736 (13) 61611–6.

2. Verhoeven, J. E., et al., “Anxiety Disorders and Accelerated Cellular Ageing,” British Journal of Psychiatry 206, no. 5 (May 2015): 371–378.

3. Cai, N., et al., “Molecular Signatures of Major Depression,” Current Biology 25, no. 9 (May 4, 2015): 1146–1156, doi:10.1016/j.cub.2015.03.008.

4. Verhoeven, J. E., et al., “Major Depressive Disorder and Accelerated Cellular Aging: Results from a Large Psychiatric Cohort Study,” Molecular Psychiatry 19, no. 8 (August 2014): 895–901, doi:10.1038/mp. 2013.151.

5. Mamdani, F., et al., “Variable Telomere Length Across Post-Mortem Human Brain Regions and Specific Reduction in the Hippocampus of Major Depressive Disorder,” Translational Psychiatry 5 (September 15, 2015): e636, doi:10.1038/tp.2015.134.

6. Zhou, Q. G., et al., “Hippocampal Telomerase Is Involved in the Modulation of Depressive Behaviors,” Journal of Neuroscience 31, no. 34 (August 24, 2011): 12258–12269, doi:10.1523/JNEUROSCI.0805–11.2011.

7. Wolkowitz, O. M., et al., “PBMC Telomerase Activity, but Not Leukocyte Telomere Length, Correlates with Hippocampal Volume in Major Depression,” Psychiatry Research 232, no. 1 (April 30, 2015): 58–64, doi:10.1016/j.pscychresns.2015.01.007.

8. Darrow, S. M. et al., “The Association between Psychiatric Disorders and Telomere Length: A Meta-analysis Involving 14,827 Persons,” Psychosomatic Medicine 78, no. 7 (September 2016): 776–87, doi:10.1097/ PSY.0000000000000356.

9. Cai et al., “Molecular Signatures of Major Depression.” (See #3 above.)

10. Verhoeven, J. E., et al., “The Association of Early and Recent Psychosocial Life Stress with Leukocyte Telomere Length,” Psychosomatic Medicine 77, no. 8 (October 2015): 882–891, doi:10.1097/PSY.0000000000000226.

11. Verhoeven, J. E., et al., “Major Depressive Disorder and Accelerated Cellular Aging: Results from a Large Psychiatric Cohort Study,” Molecular Psychiatry 19, no. 8 (August 2014): 895–901, doi:10.1038/mp.2013.151.

12. Ibid.

13. Cai et al., “Molecular Signatures of Major Depression.” (See #3 above.)

14. Eisendrath, S. J., et al., “A Preliminary Study: Efficacy of Mindfulness-Based Cognitive Therapy Versus Sertraline as First-Line Treatments for Major Depressive Disorder,” Mindfulness 6, no. 3 (June 1, 2015): 475–482, doi:10.1007/s12671–014–0280–8; and Kuyken, W., et al., “The Effectiveness and Cost-Effectiveness of Mindfulness-Based Cognitive Therapy Compared with Maintenance Antidepressant Treatment in the Prevention of Depressive Relapse/Recurrence: Results of a Randomised Controlled Trial (the PREVENT Study),” Health Technology Assessment 19, no. 73 (September 2015): 1–124, doi:10.3310/hta19730.

15. Teasdale, J. D., et al., “Prevention of Relapse/Recurrence in Major Depression by Mindfulness-Based Cognitive Therapy,” Journal of Consulting and Clinical Psychology 68, no. 4 (August 2000): 615–623.

16. Teasdale, J., M. Williams, and Z. Segal, The Mindful Way Workbook: An 8 - Week Program to Free Yourself from Depression and Emotional Distress (New York: Guilford Press, 2014).

17. Wolfson, W. & Epel, E. (2006). “Stress, post-traumatic growth, and leukocyte aging.” Poster presentation at the American Psychosomatic Society 64th Annual Meeting, Denver, Colorado, Abstract 1476.

18. Segal, Z., J. M. G. Williams, and J. Teasdale, Mindfulness-Based Cognitive Therapy for Depression , 2nd ed. (New York: Guilford Press, 2013): 74–75. (The Three minute breathing space is part of the MBCT program. Our breathing break is a modified version).

19. Bai, Z., et al., “Investigating the Effect of Transcendental Meditation on Blood Pressure: A Systematic Review and Meta-analysis,” Journal of Human Hypertension 29, no. 11 (November 2015): 653–662. doi:10.1038/ jhh.2015.6; and Cernes, R., and R. Zimlichman, “RESPeRATE: The Role of Paced Breathing in Hypertension Treatment.” Journal of the American Society of Hypertension 9, no. 1 (January 2015): 38–47, doi:10.1016/ j.jash.2014.10.002.

20. Morgan, N., M. R. Irwin, M. Chung, and C. Wang, “The Effects of Mind-Body Therapies on the Immune System: Meta-analysis,” PLOS ONE 9, no. 7 (2014): e100903, doi:10.1371/journal.pone.0100903.

21. Conklin, Q., et al., “Telomere Lengthening After Three Weeks of an Intensive Insight Meditation Retreat,” Psychoneuroendocrinology 61 (November 2015): 26–27, doi:10.1016/j.psyneuen.2015.07.462.

22. Epel, E., et al. “Meditation and Vacation Effects Impact Disease-Associated Molecular Phenotypes,” Translational Psychiatry (August 2016): 6, e880, doi: 10.1038/tp.2016.164.